Neurological complications of beta-thalassemia

Annals of Hematology

Volumn 94, Issue 8, 2015, Pages 1261-1265

  Nemtsas, P ^a   Arnaoutoglou, M ^a   Perifanis, V ^a   Koutsouraki, E ^a   Orologas, A ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Cerebrovascular disease; Desferrioxamine neurotoxicity; Extramedullary hematopoiesis; Peripheral neuropathy

Indexed keywords

BETA THALASSEMIA; CEREBROVASCULAR DISEASE; COGNITION; EVOKED BRAIN STEM AUDITORY RESPONSE; EXTRAMEDULLARY HEMATOPOIESIS; HUMAN; INTELLIGENCE QUOTIENT; LIFE EXPECTANCY; MYOPATHY; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROPHYSIOLOGICAL MONITORING; PERIPHERAL NEUROPATHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOMATOSENSORY EVOKED POTENTIAL; VISUAL EVOKED POTENTIAL;

EID: 84941115542     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-015-2378-z     Document Type: Review

References (63)

1. Rund D, Rachmilewitz E (2005) Beta-thalassemia. N Engl J Med 353:1135-1146
2. Cao A, Galanello R (2010) Beta-thalassemia. GenetMed 12:61-76
3. Aessopos A, Farmakis D, Karagiorga M et al (2001) Cardiac involvement in thalassemia intermedia: a multicenter study. Blood 97:3411-3416
4. Taher AT, Musallam KM, El-Beshlawy A et al (2010) Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol 150:486-489
5. Orsini A, Soulayrol R, Tramini F, Tasso-Perrimond AM (1967) Nervous manifestations associated with thalassemia (critical study of the concept of thalassemic neurohemolytic syndrome). Pediatrie 22:771-784
6. Monastero R, Monastero G, Ciaccio C et al (2000) Cognitive deficits in beta-thalassemia major. Acta Neurol Scand 102:162-168
7. Economou M, Zafeiriou DI, Kontopoulos E et al (2006) Neurophysiologic and intellectual evaluation of beta-thalassemia patients. Brain Dev 28:14-18
8. Metafratzi Z, Argyropoulou MI, Kiortsis DN et al (2001) T(2) relaxation rate of basal ganglia and cortex in patients with betathalassaemia major. Br J Radiol 74:407-410
9. Karimi M, Yarmohammadi H, Cappellini MD (2006) Analysis of intelligence quotient in patientswith homozygous beta-thalassemia. Saudi Med J 27:982-985
10. Duman O, Arayici S, Fettahoglu C et al (2011) Neurocognitive function in patients with beta-thalassemia major. Pediatr Int 53: 519-523
11. Teli A, Economou M, Rudolf J et al (2012) Subclinical central nervous system involvement and thrombophilic status in young thalassemia intermedia patients of Greek origin. Blood Coagul Fibrinolysis 23:195-202
12. Tony S, Daar S, Elshinawy M et al (2012) T2* MRI in regularly transfused children with thalassemia intermedia: serumferritin does not reflect liver iron stores. Pediatr Hematol Oncol 29:579-584
13. Taher AT, Musallam KM, Nasreddine W, et al (2010)Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost 8:54-59
14. Jokinen H, Lipsanen J, Schmidt R et al (2012) Brain atrophy accelerates cognitive decline in cerebral small vessel disease: the LADIS study. Neurology 78:1785-1792
15. Gelmi C, Borgna-Pignatti C, Franchin S et al (1988) Electroretinographic and visual-evoked potential abnormalities in patients with beta-thalassemia major. Ophthalmologica 196:29-34
16. Marciani MG, Cianciulli P, Stefani N et al (1991) Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function. Haematologica 76:131-134
17. Triantafyllou N, Fisfis M, Sideris G, et al (1991) Neurophysiological and neuro-otological study of homozygous beta-thalassemia under long-term desferrioxamine (DFO) treatment. Acta Neurol Scand 83:306-308
18. Wong V, Li A, Lee AC (1993) Neurophysiologic study of betathalassemia patients. J Child Neurol 8:330-335
19. Taher A, Cappellini MD (2009) Update on the use of deferasirox in the management of iron overload. Ther Clin Risk Manag 5: 857-868
20. Tourkantoni N, Athanassiou-Metaxa M, Zafiriou D et al (2008) Immune and neural status of thalassemic patients receiving deferiprone or combined deferiprone and deferoxamine chelation treatment. Hemoglobin 32:35-40
21. Gatto I, Terrana V, Biondi L (1954) Compression of the spinal cord due to proliferation of bone marrow in epidural space in a splenectomized person with Cooley’s disease. Haematologica 38: 61-76
22. Haidar R, Mhaidli H, Taher AT (2010) Paraspinal extramedullary hematopoiesis in patients with thalassemia intermedia. Eur Spine J 19:871-878
23. Orphanidou-Vlachou E, Tziakouri-Shiakalli C, Georgiades CS (2014) Extramedullary hemopoiesis. Semin Ultrasound CT MR 35:255-262
24. Aarabi B, Haghshenas M, Rakeii V (1998) Visual failure caused by suprasellar extramedullary hematopoiesis in beta thalassemia: case report. Neurosurgery 42:922-925, discussion 925-926
25. Sorcinelli R, Cacace E, Del Piano M (1999) Optic nerve compression by extramedullary hematopoietic tissue in a patient suffering from beta-thalassemia intermedia. Metab Pediatr Syst Ophthalmol 22-23:5-6
26. Meara JG, Potter C, Goodman M, Vernick D (1998) Extramedullary hematopoiesis of the middle ear in a patient with thalassemia. Am J Otolaryngol 19:287-289
27. Karimi M, Cohan N, Pishdad P (2014) Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: four case reports. Hematology
28. Logothetis J, Constantoulakis M, Economidou J et al (1972) Thalassemia major (homozygous beta-thalassemia). A survey of 138 cases with emphasis on neurologic and muscular aspects. Neurology 22:294-304
29. Borgna Pignatti C, Carnelli V, Caruso V et al (1998) Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol 99:76-79
30. Cappellini MD, Robbiolo L, Bottasso BM et al (2000) Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol 111:467-473
31. Eldor A, Durst R, Hy-Am E et al (1999) A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol 107:739-746
32. Michaeli J, Mittelman M, Grisaru D, Rachmilewitz EA (1992) Thromboembolic complications in beta thalassemia major. Acta Haematol 87:71-74
33. Haghpanah S, Karimi M (2012) Cerebral thrombosis in patients with beta-thalassemia: a systematic review. Blood Coagul Fibrinolysis 23:212-217
34. Cappellini MD, Poggiali E, Taher AT, Musallam KM (2012) Hypercoagulability in beta-thalassemia: a status quo. Expert Rev Hematol 5:505-511, quiz 512
35. Zafeiriou DI, Prengler M, Gombakis N, et al (2004) Central nervous system abnormalities in asymptomatic young patients with Sbetathalassemia. Ann Neurol 55:835-839
36. Karimi M, Khanlari M, Rachmilewitz EA (2008) Cerebrovascular accident in beta-thalassemia major (beta-TM) and beta-thalassemia intermedia (beta-TI). Am J Hematol 83:77-79
37. Taher A, Isma'eel H, Mehio G et al (2006) Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost 96:488-491
38. Vassilopoulou S, Anagnostou E, Paraskevas G, Spengos K (2011) Etiology and treatment of ischaemic stroke in patients with betathalassemia major. Eur J Neurol 18:1426-1428
39. Mavrogeni S, Bratis K, vanWijk K et al (2013) The reproducibility of cardiac and liver T2* measurement in thalassemia major using two different software packages. Int J Cardiovasc Imaging
40. McClellan W, Warnock DG, McClure L et al (2006) Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17: 1710-1715
41. Metarugcheep P, Chanyawattiwongs S, Srisubat K, Pootrakul P (2008) Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI). J Med Assoc Thai 91:889-894
42. Paolino E, Monetti VC, Granieri E, Boldrini P (1983) Acute cerebrovascular insults in homozygous beta-thalassaemia: a case report. J Neurol 230:37-41
43. Karimi M, Bagheri H, Rastgu F, Rachmilewitz EA (2010)Magnetic resonance imaging to determine the incidence of brain ischaemia in patients with beta-thalassaemia intermedia. Thromb Haemost 103: 989-993
44. Musallam KM, Taher AT, Karimi M, Rachmilewitz EA (2012) Cerebral infarction in beta-thalassemia intermedia: breaking the silence. Thromb Res 130:695-702
45. Taher AT, Musallam KM, Karimi M et al (2010) Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood 115:1886-1892
46. Taher AT, Musallam KM, Cappellini MD, Weatherall DJ (2011) Optimal management of beta thalassaemia intermedia. Br J Haematol 152:512-523
47. Musallam KM, Beydoun A, Hourani R et al (2011) Brain magnetic resonance angiography in splenectomized adults with betathalassemia intermedia. Eur J Haematol 87:539-546
48. Musallam KM, Nasreddine W, Beydoun A et al (2012) Brain positron emission tomography in splenectomized adults with betathalassemia intermedia: uncovering yet another covert abnormality. Ann Hematol 91:235-241
49. Taher AT, Musallam KM, Viprakasit V et al (2014) Iron chelation therapy for non-transfusion-dependent thalassemia (NTDT): a status quo. Blood Cells Mol Dis 52:88-90
50. Bhattacharyya M, Kannan M, Chaudhry VP et al (2007) Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost 13:422-427
51. Cappellini MD, Motta I, Musallam KM, Taher AT (2010) Redefining thalassemia as a hypercoagulable state. Ann N Y Acad Sci 1202:231-236
52. Eldor A, Rachmilewitz EA (2002) The hypercoagulable state in thalassemia. Blood 99:36-43
53. Sirachainan N (2013) Thalassemia and the hypercoagulable state. Thromb Res 132:637-641
54. Taher AT, Musallam KM, Inati A (2009) The hypercoagulable state in thalassemia intermedia. Hemoglobin 33(Suppl 1):S160-169
55. Karimi M, Haghpanah S, Bagheri MH et al (2012) Frequency and distribution of asymptomatic brain lesions in patients with betathalassemia intermedia. Ann Hematol 91:1833-1838
56. Wasi P, Na-Nakorn S, Pootrakul P et al (1978) A syndrome of hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood-transfusions. Lancet 2: 602-604
57. Constantopoulos A, Matsaniotis N (1980) Hypertension, convulsion, and cerebral haemorrhage in thalassaemic patients after multiple blood transfusions. Helv Paediatr Acta 35: 269-271
58. Masood SA, Zaidi A (2012) Post-transfusion hypertension, convulsion and intracranial haemorrhage in beta-thalassemia major. J Coll Physicians Surg Pak 22:473-475
59. Papanastasiou DA, Papanicolaou D, Magiakou AM et al (1991) Peripheral neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 54:997-1000
60. Zafeiriou DI, Kousi AA, Tsantali CT, et al (1998) Neurophysiologic evaluation of long-term desferrioxamine therapy in betathalassemia patients. Pediatr Neurol 18:420-424
61. Stamboulis E, Vlachou N, Drossou-Servou M et al (2004) Axonal sensorimotor neuropathy in patients with beta-thalassaemia. J Neurol Neurosurg Psychiatry 75:1483-1486
62. Sawaya RA, Zahed L, Taher A (2006) Peripheral neuropathy in thalassaemia. Ann Saudi Med 26:358-363
63. Nemtsas P, Perifanis V, Koutsouraki E, Orologas A, Arnaoutoglou M (2014) P627: is precautionary neurophysiological monitoring useful for beta-thalassemia patients? Clin Neurophysiol 125(Suppl 1):S219